2016 American Transplant Congress
The Impact of Different Immunosuppressive Protocols on Early and Long Term Outcomes After Kidney and Pancreas Transplantation.
Surgery/Transplant, The Ohio State University Wexner Medical Center, Columbus, OH.
Between January 1990 and December 2014, 800 combined kidney pancreas transplant procedures were performed at The Ohio State University. The immunosuppressive protocols have changed significantly…2016 American Transplant Congress
Conversion from Tacrolimus to Belatacept in Pancreas Transplant Alone Recipients with Chronic Kidney Disease.
Medicine/Nephrology & Surgery/Transplant, Indiana University, Indianapolis.
Background: CNI toxicity is a well known risk factor for chronic kidney disease and ESRD in organ transplants. We report our experience in converting Pancreas…2015 American Transplant Congress
Why Are Pancreas Transplant Volumes Declining?
Background: Pancreas transplant volumes have been decreasing in the US since the mid-2000s. It has been conjectured that poor utilization of deceased donor pancreata (as…2015 American Transplant Congress
Reconsideration of Age Limits for Pancreas Transplantation
Div. of Transplantation, Dept. of Surgery, University of Wisconsin, Madison, WI.
Introduction: Pancreas transplantation (PTx) remains the only strategy for reinstitution of long-term insulin production and outcomes have progressively improved. Yet, historically, centers have employed age-limits…2015 American Transplant Congress
Which Place of Pancreas Graft Biopsy in the Management of Pancreas Transplant Recipients?
Hospices civils de Lyon, Lyon, France.
Introduction.Rejection or autoimmune recurrence is often difficult to diagnose in the field of pancreas transplantation. The place of pancreas graft biopsy in the management of…2015 American Transplant Congress
Controlled DCD Pancreas Transplantation : A Single Centre Experience
Oxford Transplant Centre, Oxford University, Oxford, United Kingdom.
Background: The use of DCD pancreata are gaining popularity in the UK. Isolated pancreas transplantation (IP) is known to have inferior outcomes in comparison to…2015 American Transplant Congress
The Impact of Center Size on Outcome of Pancreas Transplants
Introduction: The number of pancreas transplants (PxTx) has continuously declined over the last decade. Since the number of transplant centers that perform pancreas transplants has…2015 American Transplant Congress
Dual Induction Therapy With Anti-Thymocyte Globulin and Basiliximab in Simultaneous Pancreas-Kidney Transplantation Reduced Incidence of Acute Rejection
Tokyo Women Medical University, Kidney Center, Tokyo, Kawadacho, Japan.
【Background】Induction therapy in simultaneous pancreas-kidney transplant (SPK) recipients has been a common practice because a consequence of acute rejection (AR) in SPK could result in…2015 American Transplant Congress
Invasive CMV-Infection of the Duodenal Cuff – An Underestimated Entity of CMV Infection and Its Potential Impact On Outcome After Pancreas Transplantation
IntroductionWe present data on the incidence of focal invasive CMV-infection of the duodenal cuff and its potential impact on clinical outcome after pancreas transplantation (PT).Material…2015 American Transplant Congress
Management of Pancreas Graft Splenic Vein Thrombosis: Is Conservative Management Safe?
Background: Prophylaxis for graft portal/splenic venous thrombosis following pancreas transplant varies between institutions. Similarly, treatment of venous thrombosis ranges from early re-exploration to conservative management…
- « Previous Page
- 1
- …
- 22
- 23
- 24
- 25
- 26
- …
- 28
- Next Page »